BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12377329)

  • 1. Prognostic value of vascular endothelial growth factor in Stage IB carcinoma of the uterine cervix.
    Lee IJ; Park KR; Lee KK; Song JS; Lee KG; Lee JY; Cha DS; Choi HI; Kim DH; Deung YK
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):768-79. PubMed ID: 12377329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different angiogenic pathways in human cervical cancers.
    Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
    Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between vascular endothelial growth factor, microvessel density and clinicopathological features in invasive cervical cancer.
    Tjalma W; Weyler J; Weyn B; Van Marck E; Van Daele A; Van Dam P; Goovaerts G; Buytaert P
    Eur J Obstet Gynecol Reprod Biol; 2000 Oct; 92(2):251-7. PubMed ID: 10996690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
    Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue expression of VEGF as a prognostic factor in early cervical squamous cell carcinoma.
    Terlikowski S; Lenczewski A; Sulkowska M; Famulski W; Sulkowski S; Kulikowski M
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():112-3. PubMed ID: 11820564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microvessel density, epithelial-stromal vascular cuffing and expression of vascular endothelial growth factor in human cervical carcinoma].
    Yao JF; Ji YF; Shi YF
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Feb; 32(1):62-6. PubMed ID: 12640714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor and prognosis of cervical carcinoma.
    Cheng WF; Chen CA; Lee CN; Wei LH; Hsieh FJ; Hsieh CY
    Obstet Gynecol; 2000 Nov; 96(5 Pt 1):721-6. PubMed ID: 11042307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
    Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
    Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
    O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
    Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of Erb-b2 immunostaining in cervical cancer.
    Nevin J; Laing D; Kaye P; McCulloch T; Barnard R; Silcocks P; Blackett T; Paterson M; Sharp F; Cruse P
    Gynecol Oncol; 1999 Jun; 73(3):354-8. PubMed ID: 10366459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-erbB-2 oncoprotein overexpression in uterine cervix carcinoma with glandular differentiation. A frequent event but not an independent prognostic marker because it occurs late in the disease.
    Costa MJ; Walls J; Trelford JD
    Am J Clin Pathol; 1995 Dec; 104(6):634-42. PubMed ID: 8526205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Brunetto VL; Clarke-Pearson DL; Averette HE; Major FJ; Alvarez RD; Homesley HD; Zaino RJ
    Gynecol Oncol; 1996 Dec; 63(3):304-11. PubMed ID: 8946863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vascular endothelial growth factor and its receptor KDR (kinase domain-containing receptor)/Flk-1 (fetal liver kinase-1) as prognostic factors in human colorectal cancer.
    Harada Y; Ogata Y; Shirouzu K
    Int J Clin Oncol; 2001 Oct; 6(5):221-8. PubMed ID: 11723743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
    Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma.
    Gasparini G; Toi M; Gion M; Verderio P; Dittadi R; Hanatani M; Matsubara I; Vinante O; Bonoldi E; Boracchi P; Gatti C; Suzuki H; Tominaga T
    J Natl Cancer Inst; 1997 Jan; 89(2):139-47. PubMed ID: 8998183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
    Fine BA; Valente PT; Feinstein GI; Dey T
    Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
    Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
    Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.